Mihael Hristos Polymeropoulos, President and CEO at Vanda Pharmaceuticals Inc. (VNDA), sold 191,800 shares at $10.62 ($2.0M) on 2022-12-05, disclosed to the SEC on 2022-12-07.
Seasonal sale ($2.0M) by President and CEO — this insider has traded VNDA in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.62 | 47,650 | $506K | 24.9% |
| 2 | $10.62 | 47,650 | $506K | 24.9% |
| 3 | $10.61 | 48,250 | $512K | 25.1% |
| 4 | $10.61 | 48,250 | $512K | 25.1% |
| Total | $10.61 avg | 191,800 | $2.0M | 100% |
| Filing → |
| VNDA | BUY | 2025-05-21 | $44K | — | Filing → |
| VNDA | BUY | 2025-05-19 | $84K | — | Filing → |
| VNDA | BUY | 2025-03-06 | $50K | — | Filing → |